These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 32620930)

  • 1. A novel silkworm infection model with fluorescence imaging using transgenic Trichosporon asahii expressing eGFP.
    Matsumoto Y; Yamazaki H; Yamasaki Y; Tateyama Y; Yamada T; Sugita T
    Sci Rep; 2020 Jul; 10(1):10991. PubMed ID: 32620930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
    Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
    Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
    Sun W; Su J; Xu S; Yan D
    J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and antifungal susceptibility testing of Trichosporon asahii in Ceará, Brazil.
    Menezes EA; Marinho JA; Angelo MR; Cunha Mda C; Cunha FA; Vasconcelos Júnior AA
    Rev Inst Med Trop Sao Paulo; 2012; 54(1):1-3. PubMed ID: 22370746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres.
    Francisco EC; de Almeida Junior JN; de Queiroz Telles F; Aquino VR; Mendes AVA; de Andrade Barberino MGM; de Tarso O Castro P; Guimarães T; Hahn RC; Padovan ACB; Chaves GM; Colombo AL
    Clin Microbiol Infect; 2019 Jul; 25(7):909.e1-909.e5. PubMed ID: 30991116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.
    Tsai MS; Yang YL; Wang AH; Wang LS; Lu DC; Liou CH; Hsieh LY; Wu CJ; Cheng MF; Shi ZY; Lo HJ
    Mycopathologia; 2012 Aug; 174(2):121-30. PubMed ID: 22318636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients.
    Xia Z; Yang R; Wang W; Cong L
    Mycopathologia; 2012 Mar; 173(2-3):127-33. PubMed ID: 21979867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biofilm formation and antifungal susceptibility of Trichosporon asahii isolates from Mexican patients.
    Montoya AM; Elizondo-Zertuche M; Treviño-Rangel RJ; Becerril-García M; González GM
    Rev Iberoam Micol; 2018; 35(1):22-26. PubMed ID: 29287630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India.
    Rastogi V; Honnavar P; Rudramurthy SM; Pamidi U; Ghosh A; Chakrabarti A
    Mycoses; 2016 Aug; 59(8):528-34. PubMed ID: 27144725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated Trichosporon asahii infection in a combined liver-kidney transplant recipient successfully treated with voriconazole.
    Sah R; Soin AS; Chawla S; Wadhwa T; Gupta N
    Immun Inflamm Dis; 2019 Sep; 7(3):125-129. PubMed ID: 31006179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of efflux pumps and
    Abbes S; Sellami H; Neji S; Trabelsi H; Makni F; Ayadi A
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33688802
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of an efficient gene-targeting system for elucidating infection mechanisms of the fungal pathogen Trichosporon asahii.
    Matsumoto Y; Nagamachi T; Yoshikawa A; Yamazaki H; Yamasaki Y; Yamada T; Sugita T
    Sci Rep; 2021 Sep; 11(1):18270. PubMed ID: 34521867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MALDI-TOF MS characterisation, genetic diversity and antifungal susceptibility of Trichosporon species from Iranian clinical samples.
    Ahangarkani F; Ilkit M; Vaseghi N; Zahedi N; Zomorodian K; Khodavaisy S; Afsarian MH; Abbasi K; de Groot T; Meis JF; Badali H
    Mycoses; 2021 Aug; 64(8):918-925. PubMed ID: 33998718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenicity of Trichosporon asahii in a murine model of disseminated trichosporonosis.
    Yang RY; Wang WL; Ao JH; Hao ZF; Zhang J; Wang CM
    Chin Med J (Engl); 2008 Dec; 121(24):2557-60. PubMed ID: 19187595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antifungal susceptibility and drug-resistant mechanism of Trichosporon].
    Kushima H; Tokimatsu I; Ishii H; Kadota J
    Med Mycol J; 2015; 56(4):J123-8. PubMed ID: 26617108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance.
    Di Bonaventura G; Pompilio A; Picciani C; Iezzi M; D'Antonio D; Piccolomini R
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3269-76. PubMed ID: 17005804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Antifungal Activity of Sertraline and Synergistic Effects in Combination with Antifungal Drugs against Planktonic Forms and Biofilms of Clinical Trichosporon asahii Isolates.
    Cong L; Liao Y; Yang S; Yang R
    PLoS One; 2016; 11(12):e0167903. PubMed ID: 27930704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the resistance mechanisms in Trichosporon asahii: Triazoles as the last defense for invasive trichosporonosis.
    Padovan ACB; Rocha WPDS; Toti ACM; Freitas de Jesus DF; Chaves GM; Colombo AL
    Fungal Genet Biol; 2019 Dec; 133():103267. PubMed ID: 31513917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma.
    Itoh K; Iwasaki H; Negoro E; Shigemi H; Tokimatsu I; Tsutani H; Yamauchi T
    Mycopathologia; 2021 Mar; 186(1):113-117. PubMed ID: 33389484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role of calcineurin in stress responses, hyphal formation, and virulence of the pathogenic fungus Trichosporon asahii.
    Matsumoto Y; Yoshikawa A; Nagamachi T; Sugiyama Y; Yamada T; Sugita T
    Sci Rep; 2022 Sep; 12(1):16126. PubMed ID: 36167890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.